The impact of publicly funded family planning clinic services on unintended pregnancies and government cost savings

J Health Care Poor Underserved. 2008 Aug;19(3):778-96. doi: 10.1353/hpu.0.0060.

Abstract

Publicly funded family planning clinics serve millions of low-income women each year, providing a range of critical preventive services and enabling women to avoid unintended pregnancies. It is important to quantify the impact and cost-effectiveness of such services, in addition to these health benefits. Using a methodology similar to prior cost-benefit analyses, we estimated the numbers of unintended pregnancies prevented by all U.S. publicly funded family planning clinics in 2004, nationally (1.4 million pregnancies) and for each state. We also compared the actual costs of providing these services ($1.4 billion) with the anticipated public-sector costs for maternity and infant care among the Medicaid-eligible women whose births were averted ($5.7 billion) to calculate net public-sector savings ($4.3 billion). Thus, public expenditures for family planning care not only help women to achieve their childbearing goals, but they also save public dollars: Our calculations indicate that for every $1 spent, $4.02 is saved.

Publication types

  • Evaluation Study
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Community Health Centers / economics*
  • Community Health Centers / statistics & numerical data
  • Contraceptive Agents, Female / economics
  • Contraceptive Agents, Female / supply & distribution
  • Cost Savings
  • Cost-Benefit Analysis
  • Demography
  • Family Planning Services / economics*
  • Family Planning Services / methods
  • Family Planning Services / statistics & numerical data
  • Federal Government
  • Female
  • Financing, Government / classification
  • Financing, Government / statistics & numerical data*
  • Humans
  • Likelihood Functions
  • Medicaid
  • Pregnancy
  • Pregnancy, Unplanned*
  • Program Evaluation*
  • State Government
  • United States

Substances

  • Contraceptive Agents, Female